Answers are grounded in this paper and cite their sources.
Observational analysis links chemotherapy response score to recurrence patterns in patients, suggesting targeted treatment strategies.
CRS3 predicts lower recurrence risk, increased rates of oligometastatic relapse, and greater use of locoregional treatments in patients with recurrent HGSOC after NACT and IDS.
No takes yet. Share an insight, caveat, or question.
Mezzapesa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: